| Primary |
| Hypertonic Bladder |
27.7% |
| Product Used For Unknown Indication |
26.0% |
| Drug Use For Unknown Indication |
9.3% |
| Urinary Incontinence |
5.5% |
| Pollakiuria |
4.7% |
| Micturition Urgency |
4.2% |
| Hypertension |
3.8% |
| Diabetes Mellitus |
2.8% |
| Incontinence |
2.7% |
| Bladder Disorder |
1.7% |
| Blood Pressure |
1.7% |
| Depression |
1.5% |
| Blood Cholesterol |
1.1% |
| Blood Cholesterol Increased |
1.1% |
| Type 2 Diabetes Mellitus |
1.1% |
| Urinary Tract Disorder |
1.1% |
| Asthma |
0.9% |
| Bladder Spasm |
0.9% |
| Constipation |
0.9% |
| Gastrooesophageal Reflux Disease |
0.9% |
|
| Constipation |
15.9% |
| Dry Mouth |
15.4% |
| Drug Ineffective |
12.1% |
| Vision Blurred |
9.3% |
| Urinary Retention |
5.5% |
| Diarrhoea |
4.4% |
| Dysuria |
4.4% |
| Nausea |
3.3% |
| Pollakiuria |
3.3% |
| Dizziness |
2.7% |
| Headache |
2.7% |
| Pain |
2.7% |
| Therapeutic Response Decreased |
2.7% |
| Abdominal Pain |
2.2% |
| Abdominal Pain Upper |
2.2% |
| Insomnia |
2.2% |
| Pain In Extremity |
2.2% |
| Pruritus |
2.2% |
| Urinary Incontinence |
2.2% |
| Urinary Tract Infection |
2.2% |
|
| Secondary |
| Hypertonic Bladder |
19.2% |
| Product Used For Unknown Indication |
10.6% |
| Micturition Urgency |
8.7% |
| Pollakiuria |
7.7% |
| Drug Use For Unknown Indication |
6.7% |
| Urinary Retention |
5.8% |
| Incontinence |
4.8% |
| Memory Impairment |
4.8% |
| Bladder Disorder |
3.8% |
| Dyspepsia |
3.8% |
| Glaucoma |
2.9% |
| Parkinson's Disease |
2.9% |
| Sleep Apnoea Syndrome |
2.9% |
| Urinary Incontinence |
2.9% |
| Urinary Tract Disorder |
2.9% |
| Antidepressant Therapy |
1.9% |
| Cystitis |
1.9% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Mineral Supplementation |
1.9% |
| Muscle Spasms |
1.9% |
|
| Constipation |
11.8% |
| Dry Mouth |
8.8% |
| Productive Cough |
8.8% |
| Drug Ineffective |
5.9% |
| Flatulence |
5.9% |
| Incorrect Dose Administered |
5.9% |
| Nocturia |
5.9% |
| Therapeutic Response Decreased |
5.9% |
| Tongue Discolouration |
5.9% |
| Urinary Incontinence |
5.9% |
| Abdominal Pain |
2.9% |
| Blood Pressure Increased |
2.9% |
| Cough |
2.9% |
| Cystitis |
2.9% |
| Dermatitis Bullous |
2.9% |
| Dyspepsia |
2.9% |
| Heart Rate Increased |
2.9% |
| Insomnia |
2.9% |
| Nausea |
2.9% |
| Pyrexia |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
12.5% |
| Multiple Sclerosis |
10.0% |
| Depression |
8.5% |
| Constipation |
5.9% |
| Gastrooesophageal Reflux Disease |
5.9% |
| Respiratory Disorder |
5.9% |
| Pain |
5.2% |
| Insomnia |
4.8% |
| Diabetes Mellitus |
4.4% |
| Parkinson's Disease |
4.4% |
| Osteoporosis |
4.1% |
| Anxiety |
3.7% |
| Cardiac Disorder |
3.7% |
| Drug Use For Unknown Indication |
3.3% |
| Fluid Retention |
3.3% |
| Muscle Spasticity |
3.3% |
| Neuropathy Peripheral |
3.0% |
| Rheumatoid Arthritis |
3.0% |
| Atrial Fibrillation |
2.6% |
| Urinary Incontinence |
2.6% |
|
| Urinary Tract Infection |
11.6% |
| Headache |
9.3% |
| Tremor |
9.3% |
| Multiple Sclerosis Relapse |
7.0% |
| Altered State Of Consciousness |
4.7% |
| Cystitis |
4.7% |
| Emotional Distress |
4.7% |
| Irritable Bowel Syndrome |
4.7% |
| Nausea |
4.7% |
| Oedema Peripheral |
4.7% |
| Product Quality Issue |
4.7% |
| Renal Disorder |
4.7% |
| Renal Failure Acute |
4.7% |
| Speech Disorder |
4.7% |
| Urinary Incontinence |
4.7% |
| Back Pain |
2.3% |
| Cataract |
2.3% |
| Depression |
2.3% |
| Device Related Infection |
2.3% |
| Dizziness |
2.3% |
|
